GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Becn1 | decreases expression | ISO | Becn1 (Mus musculus) | 6480464 | CTD | Cyclophosphamide results in decreased expression of BECN1 protein | PMID:32151603 | Becn1 | increases expression | ISO | Becn1 (Mus musculus) | 6480464 | CTD | Cyclophosphamide results in increased expression of BECN1 protein | PMID:38348709 | Becn1 | multiple interactions | ISO | BECN1 (Homo sapiens) | 6480464 | CTD | BECN1 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | PMID:16896004 | Becn1 | multiple interactions | ISO | Becn1 (Mus musculus) | 6480464 | CTD | asperuloside promotes the reaction [Cyclophosphamide results in increased expression of BECN1 protein]; CSF2 protein promotes the reaction [Cyclophosphamide results in increased expression of BECN1 protein]; dorsomorphin inhibits the reaction [asperuloside promotes the reaction [Cyclophosphamide results in increased expression of BECN1 protein]]; dorsomorphin inhibits the reaction [Cyclophosphamide results in increased expression of BECN1 protein]; Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of BECN1 protein]; Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of BECN1 protein] | PMID:32151603 PMID:38348709 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |